CA19-9 and apolipoprotein-A2 isoforms as detection markers for pancreatic cancer: a prospective evaluation.

MLA

Honda, Kazufumi, et al. “CA19-9 and Apolipoprotein-A2 Isoforms as Detection Markers for Pancreatic Cancer: A Prospective Evaluation.” International Journal of Cancer, vol. 144, no. 8, Apr. 2019, pp. 1877–87. EBSCOhost, https://doi.org/10.1002/ijc.31900.

APA

Honda, K., Katzke, V. A., Hüsing, A., Okaya, S., Shoji, H., Onidani, K., Olsen, A., Tjønneland, A., Overvad, K., Weiderpass, E., Vineis, P., Muller, D., Tsilidis, K., Palli, D., Pala, V., Tumino, R., Naccarati, A., Panico, S., Aleksandrova, K., … Kaaks, R. (2019). CA19-9 and apolipoprotein-A2 isoforms as detection markers for pancreatic cancer: a prospective evaluation. International Journal of Cancer, 144(8), 1877–1887. https://doi.org/10.1002/ijc.31900

Chicago

Honda, Kazufumi, Verena A Katzke, Anika Hüsing, Shinobu Okaya, Hirokazu Shoji, Kaoru Onidani, Anja Olsen, et al. 2019. “CA19-9 and Apolipoprotein-A2 Isoforms as Detection Markers for Pancreatic Cancer: A Prospective Evaluation.” International Journal of Cancer 144 (8): 1877–87. doi:10.1002/ijc.31900.